<?xml version="1.0" encoding="UTF-8"?>
<p id="par0105">OL is an employee of and holds equity in Inflammatix Inc., developing host response based tests for acute infections and sepsis. Inflammatix does not have a commercial presence anywhere in the world at this time. All other authors: none declared.</p>
